Significados de decompensated cirrhosis en inglés

Liver transplantation is indicated in patients with fulminant liver failure or decompensated cirrhosis.

There were no significant differences in spectra from livers with compensated and decompensated cirrhosis.

We analyzed the impact of these complications on treatment revenues in hospitalized patients with decompensated cirrhosis.

Background: Several lines of evidence indicate that decompensated cirrhosis is characterized by the presence of systemic inflammation.

Conclusion: Worsening renal function in decompensated cirrhosis is accompanied by progressive elevation in plasma NOx and L-Arg.

We modelled prevalence of total, compensated, and decompensated cirrhosis on the basis of hospital and claims data.

Three patients presenting with acute liver failure and the two with decompensated cirrhosis underwent successful liver transplantation.

OP is safe in healthy subjects and in stable patients with cirrhosis, but there are no data in decompensated cirrhosis.

There was a significant increase in age-standardised prevalence rate of decompensated cirrhosis between 1990 and 2017.

However, HVPG has a limited role in the prediction of death in decompensated cirrhosis due to its invasiveness and limited use.

Hepatorenal syndrome (HRS) is one of the most ominous complications of portal hypertension in patients with decompensated cirrhosis and ascites.

Background and aims: Increased levels of nitric oxide (NO) are hypothesized to contribute to renal dysfunction in patients with decompensated cirrhosis.

Peak plasma concentrations were reached within 2-3 h, although more variability was observed among patients with decompensated cirrhosis.

Four patients presented with acute liver failure, four with persistently elevated liver function tests, and two with decompensated cirrhosis; none had neurological manifestations.

Methods: We used data from 136 consecutive patients with decompensated cirrhosis who underwent HVPG between January 2006 and June 2008.

Interferon alpha therapy of hepatitis B virus-related decompensated cirrhosis with the dose and the duration generally used is frequently associated with severe side-effects and reactivations.